Optinose to Present at the Needham Virtual Healthcare Conference
Rhea-AI Summary
Optinose (NASDAQ:OPTN), a specialty pharmaceutical company, will present a company overview and business update at the Needham Virtual Healthcare Conference on April 12, 2022, at 11:45 a.m. ET. Interested parties can listen to the live webcast on Optinose's Investors page, with a replay available for 60 days post-event. The company focuses on patients treated by ENT and allergy specialists. For more information, visit www.optinose.com.
Positive
- None.
Negative
- None.
News Market Reaction – OPTN
In the trading session that priced this news, OPTN declined 1.15%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
AI-generated analysis. How Rhea-AI works. Not financial advice.
YARDLEY, Pa., April 08, 2022 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the Needham Virtual Healthcare Conference on April 12, 2022 at 11:45 a.m. ET.
To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.
A replay of the webcast will be available for 60 days following the conclusion of the event.
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
